Checkpoint Capital’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67M | Buy |
1,060,000
+152,760
| +17% | +$9.65M | 31.21% | 2 |
|
|
2025
Q1 | $48.1M | Buy |
907,240
+179,258
| +25% | +$9.5M | 26.37% | 2 |
|
|
2024
Q4 | $40.8M | Buy |
727,982
+64,601
| +10% | +$3.62M | 20.74% | 2 |
|
|
2024
Q3 | $34.8M | Sell |
663,381
-258,719
| -28% | -$13.6M | 17.24% | 2 |
|
|
2024
Q2 | $37.9M | Buy |
922,100
+96,600
| +12% | +$3.97M | 22.82% | 1 |
|
|
2024
Q1 | $35.8M | Buy |
825,500
+95,500
| +13% | +$4.14M | 23.91% | 1 |
|
|
2023
Q4 | $33.6M | Buy |
+730,000
| New | +$33.6M | 20.33% | 1 |
|